Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

Brief summary (registry, in English)

The purpose of this study is to assess the safety and efficacy of long-term use of Duodopa in patients with Parkinkon's disease in actual usage

What you commit to

• Study type: Observational
• Participants enrolled: 839
• From 12 Sept 2016 to the primary completion date, 24 Jul 2025
• 127 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (127)

Sites in registry order. Pick your city on the disease page to sort them by distance.